A contemporary downtrend in chronic GVHD?

Blood Adv. 2024 Nov 26;8(22):5875-5877. doi: 10.1182/bloodadvances.2024014586.

Authors

Najla El Jurdi¹, Steven Z Pavletic¹

Affiliation

¹ Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

PMID: 39546299
DOI: 10.1182/bloodadvances.2024014586

No abstract available